| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6821830 | Schizophrenia Research | 2018 | 8 Pages |
Abstract
Using certain exclusion criteria in RCTs may impact the drug's effect estimate, particularly when exclusion criteria are AP effect-modifiers representing frequent characteristics among patients with schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Clementine Nordon, Thomas Bovagnet, Mark Belger, Javier Jimenez, Robert Olivares, Helene Chevrou-Severac, Helene Verdoux, Josep Maria Haro, Lucien Abenhaim, Helene Karcher, on behalf of the IMI GetReal WP2 group on behalf of the IMI GetReal WP2 group,